Phoenix Asia Holdings Ltd operates its business through its indirectly wholly-owned Operating Subsidiary... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ROE | 42.31 | 0.01 | +0.01% |
| Astoria US Equal Weight Quality Kings ETF (ROE) | |||
| AIOO | 26.43 | N/A | -0.02% |
| AllianzIM U.S. Equity Buffer100 Protection ETF (AIOO) | |||
| VO | 81.52 | -0.03 | -0.04% |
| Vanguard Morningstar Mid-Cap ETF (VO) | |||
| GENZ | 37.62 | -0.11 | -0.29% |
| VanEck Digital Native Economy ETF (GENZ) | |||
| NUGT | 138.19 | -16.09 | -10.43% |
| Direxion Daily Gold Miners Index Bull 2X ETF (NUGT) | |||
A.I.dvisor tells us that PHOE and ROAD have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHOE and ROAD's prices will move in lockstep.
| Ticker / NAME | Correlation To PHOE | 1D Price Change % | ||
|---|---|---|---|---|
| PHOE | 100% | -5.28% | ||
| ROAD - PHOE | 20% Poorly correlated | -4.29% | ||
| STRL - PHOE | 8% Poorly correlated | -0.38% | ||
| ECG - PHOE | 2% Poorly correlated | +1.54% | ||
| FFTT - PHOE | 2% Poorly correlated | +4.38% | ||
| AMTM - PHOE | 1% Poorly correlated | +3.54% | ||
More | ||||
| Ticker / NAME | Correlation To PHOE | 1D Price Change % |
|---|---|---|
| PHOE | 100% | -5.28% |
| Engineering & Construction industry (51 stocks) | -15% Poorly correlated | +0.85% |
Industry EngineeringConstruction
The RSI Oscillator for PHOE moved out of oversold territory on October 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 1 similar instances when the indicator left oversold territory. In 1 of the 1 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Moving Average Convergence Divergence (MACD) for PHOE just turned positive on October 29, 2026. Looking at past instances where PHOE's MACD turned positive, the stock continued to rise in 9 of 10 cases over the following month. The odds of a continued upward trend are 90%.
Following a +13.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where PHOE advanced for three days, in 70 of 75 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
PHOE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 10 of 11 cases where PHOE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PHOE as a result. In 24 of 26 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PHOE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for PHOE entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. PHOE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (66.667) is normal, around the industry mean (15.143). P/E Ratio (689.509) is within average values for comparable stocks, (167.534). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.522). Dividend Yield (0.000) settles around the average of (0.215) among similar stocks. PHOE's P/S Ratio (60.976) is very high in comparison to the industry average of (2.886).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PHOE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.